Financials data is unavailable for this security.
View more
Year on year Bioqual Inc 's revenues fell -5.27% from 66.15m to 62.66m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 5.26m to 835.55k, a -84.12% decrease.
| Gross margin | 14.13% |
|---|---|
| Net profit margin | 1.52% |
| Operating margin | 1.45% |
| Return on assets | 1.59% |
|---|---|
| Return on equity | 2.48% |
| Return on investment | 1.80% |
More ▼
Cash flow in USDView more
In 2023, Bioqual Inc increased its cash reserves by 233.27%, or 5.10m. The company earned 8.23m from its operations for a Cash Flow Margin of 13.13%. In addition the company used 2.24m on investing activities and also paid 894.42k in financing cash flows.
| Cash flow per share | 3.92 |
|---|---|
| Price/Cash flow per share | 17.85 |
| Book value per share | 43.41 |
|---|---|
| Tangible book value per share | 42.26 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.22 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -20.00% and -84.12%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.00% |
|---|---|
| Div growth rate (5 year) | 10.76% |
| Payout ratio (TTM) | 46.73% |
| EPS growth(5 years) | -25.28 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -72.06 |
More ▼
